Welcome to our dedicated page for SS Innovations SEC filings (Ticker: SSII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating regulatory nuggets about the SSi Mantra surgical robotic system inside a 300-page filing is tedious. SS Innovations’ disclosures span R&D spending for new cardiac instruments, global regulatory milestones, and surgeon adoption metrics—layers of detail that can slow decision-making.
Stock Titan solves that problem. Our AI reads every SS Innovations quarterly earnings report 10-Q filing, flags changes in production costs, and translates medical-device jargon into plain language. Wondering about SS Innovations insider trading Form 4 transactions? Receive real-time alerts the moment executives trade shares, complete with context you can understand in seconds. From the latest SS Innovations annual report 10-K simplified to a sudden SS Innovations 8-K material events explained, every document arrives on your screen as soon as it hits EDGAR—already summarized.
Use cases investors rely on daily:
- Compare R&D outlays across robotic platforms with our AI-driven 10-K analysis
- Track SS Innovations executive stock transactions Form 4 before product-launch announcements
- Review surgeon-training commitments buried in the proxy—SS Innovations proxy statement executive compensation details included
Whether you need SS Innovations SEC filings explained simply or deep SS Innovations earnings report filing analysis, our platform delivers comprehensive coverage—10-Ks, 10-Qs, 8-Ks, S-1s, and more—paired with clear, AI-powered insights so you can act with confidence.
Insider transactions reported for SS Innovations International, Inc. (SSII) by Sudhir Srivastava, Chairman and CEO. The filing shows two non-derivative transactions in early September 2025: on 09/03/2025 Mr. Srivastava was reported as acquiring 2,500 shares, and on 09/05/2025 he was reported as disposing of 105,000 shares. After these transactions, the total shares beneficially owned attributable to Mr. Srivastava through Sushruta Pvt. Ltd. is reported as 112,583,014 shares. The form states the holdings are indirect because the reporting person has a controlling interest in Sushruta Pvt. Ltd.
Sudhir Srivastava, identified as a Director, 10% owner and the company's Chairman and CEO, reported a series of non-derivative transactions in the common stock of SS Innovations International, Inc. (SSII) executed through an entity he controls, Sushruta Pvt. Ltd. The Form 4 shows multiple acquisitions and dispositions between 05/12/2025 and 08/11/2025, including total reported acquisitions of 60,000 shares and total reported dispositions of 111,000 shares. After the last reported transaction the beneficial ownership held indirectly by Sushruta Pvt. Ltd. is shown as 112,685,514 common shares. Table II (derivative securities) contains no entries. The filing includes an explanatory note that the reporting person has a controlling interest in Sushruta Pvt. Ltd., which holds the securities of record.
What happened: SS Innovations reported strong sales growth this quarter and in the first half of 2025, driven by system and instrument sales. Total revenue for the quarter was $10.0M and for the first six months $15.1M. Gross profit rose and operating results improved to a small positive operating income for the quarter, and the company completed an uplisting to NASDAQ.
Why it matters: The company boosted cash to $17.6M after financings and conversions, which helps near-term operations, but it still reported a $5.94M net loss for the first half and a small quarterly net loss after tax. Management discloses substantial doubt about the company’s ability to continue as a going concern and notes dependence on related-party financing and convertible note conversions.
FAQ
What is the current stock price of SS Innovations (SSII)?
What is the market cap of SS Innovations (SSII)?
